KLF4 and bronchopulmonary dysplasia: As miR-34a-5p has been shown to have a significant role in the pathogenesis of BPD, inhibiting miR-34a-5p or associated senescence molecules such as KLF4 may be a promising therapeutic intervention for BPD.